nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—Epinastine—HTR7—Parkinson's disease	0.00971	0.0538	CrCbGaD
Oxcarbazepine—Modafinil—SLC6A3—Parkinson's disease	0.00585	0.0324	CrCbGaD
Oxcarbazepine—Mianserin—HTR7—Parkinson's disease	0.00562	0.0311	CrCbGaD
Oxcarbazepine—Mianserin—DRD3—Parkinson's disease	0.00528	0.0293	CrCbGaD
Oxcarbazepine—Mianserin—SLC6A3—Parkinson's disease	0.00491	0.0272	CrCbGaD
Oxcarbazepine—Epinastine—HTR2A—Parkinson's disease	0.00488	0.0271	CrCbGaD
Oxcarbazepine—Epinastine—CYP2D6—Parkinson's disease	0.00446	0.0247	CrCbGaD
Oxcarbazepine—Mianserin—HTR1A—Parkinson's disease	0.00431	0.0239	CrCbGaD
Oxcarbazepine—Trimipramine—SLC6A3—Parkinson's disease	0.00414	0.0229	CrCbGaD
Oxcarbazepine—Nortriptyline—HTR1A—Parkinson's disease	0.00385	0.0213	CrCbGaD
Oxcarbazepine—Promazine—DRD1—Parkinson's disease	0.0037	0.0205	CrCbGaD
Oxcarbazepine—Mianserin—DRD2—Parkinson's disease	0.00365	0.0203	CrCbGaD
Oxcarbazepine—Trimipramine—HTR1A—Parkinson's disease	0.00362	0.0201	CrCbGaD
Oxcarbazepine—Desipramine—SLC6A3—Parkinson's disease	0.00362	0.02	CrCbGaD
Oxcarbazepine—Imipramine—HTR7—Parkinson's disease	0.00351	0.0194	CrCbGaD
Oxcarbazepine—Amitriptyline—HTR7—Parkinson's disease	0.00348	0.0193	CrCbGaD
Oxcarbazepine—Doxepin—HTR1A—Parkinson's disease	0.00345	0.0191	CrCbGaD
Oxcarbazepine—Amitriptyline—DRD3—Parkinson's disease	0.00328	0.0182	CrCbGaD
Oxcarbazepine—Nortriptyline—DRD2—Parkinson's disease	0.00327	0.0181	CrCbGaD
Oxcarbazepine—Epinastine—ABCB1—Parkinson's disease	0.00319	0.0177	CrCbGaD
Oxcarbazepine—Desipramine—HTR1A—Parkinson's disease	0.00317	0.0176	CrCbGaD
Oxcarbazepine—Nortriptyline—CYP2E1—Parkinson's disease	0.00314	0.0174	CrCbGaD
Oxcarbazepine—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00314	0.00383	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—MTHFR—Parkinson's disease	0.00309	0.00377	CbGpPWpGaD
Oxcarbazepine—Trimipramine—DRD2—Parkinson's disease	0.00308	0.017	CrCbGaD
Oxcarbazepine—Imipramine—SLC6A3—Parkinson's disease	0.00307	0.017	CrCbGaD
Oxcarbazepine—CYP2C19—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00305	0.00373	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—HSPA8—Parkinson's disease	0.00301	0.00367	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—MAOB—Parkinson's disease	0.00298	0.00364	CbGpPWpGaD
Oxcarbazepine—Promethazine—DRD2—Parkinson's disease	0.00296	0.0164	CrCbGaD
Oxcarbazepine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00295	0.0036	CbGpPWpGaD
Oxcarbazepine—Doxepin—DRD2—Parkinson's disease	0.00293	0.0162	CrCbGaD
Oxcarbazepine—ALB—Lipid and lipoprotein metabolism—APOE—Parkinson's disease	0.00292	0.00357	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—APOE—Parkinson's disease	0.00288	0.00351	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—SOD2—Parkinson's disease	0.00286	0.00348	CbGpPWpGaD
Oxcarbazepine—Mianserin—HTR2A—Parkinson's disease	0.00282	0.0157	CrCbGaD
Oxcarbazepine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00282	0.00344	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—DLG4—Parkinson's disease	0.00282	0.00344	CbGpPWpGaD
Oxcarbazepine—ALB—FOXA2 and FOXA3 transcription factor networks—INS—Parkinson's disease	0.00277	0.00337	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—GRIN2B—Parkinson's disease	0.00276	0.00336	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—GPX1—Parkinson's disease	0.00272	0.00332	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—SOD1—Parkinson's disease	0.00272	0.00332	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00271	0.0033	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00269	0.00328	CbGpPWpGaD
Oxcarbazepine—Desipramine—DRD2—Parkinson's disease	0.00269	0.0149	CrCbGaD
Oxcarbazepine—Imipramine—HTR1A—Parkinson's disease	0.00269	0.0149	CrCbGaD
Oxcarbazepine—Amitriptyline—HTR1A—Parkinson's disease	0.00267	0.0148	CrCbGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00261	0.00318	CbGpPWpGaD
Oxcarbazepine—Promazine—DRD2—Parkinson's disease	0.00261	0.0144	CrCbGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—Parkinson's disease	0.00259	0.00316	CbGpPWpGaD
Oxcarbazepine—Desipramine—CYP2E1—Parkinson's disease	0.00259	0.0143	CrCbGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTA4—Parkinson's disease	0.00259	0.00315	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—IGF2—Parkinson's disease	0.00258	0.00315	CbGpPWpGaD
Oxcarbazepine—Mianserin—CYP2D6—Parkinson's disease	0.00258	0.0143	CrCbGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00255	0.00311	CbGpPWpGaD
Oxcarbazepine—Nortriptyline—HTR2A—Parkinson's disease	0.00252	0.014	CrCbGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—SOD1—Parkinson's disease	0.00252	0.00307	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—MTHFR—Parkinson's disease	0.00251	0.00307	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—Parkinson's disease	0.00246	0.003	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—INS—Parkinson's disease	0.00246	0.003	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—HGF—Parkinson's disease	0.00244	0.00298	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00243	0.00296	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00239	0.00292	CbGpPWpGaD
Oxcarbazepine—Trimipramine—HTR2A—Parkinson's disease	0.00238	0.0132	CrCbGaD
Oxcarbazepine—Diazepam—CYP2E1—Parkinson's disease	0.00238	0.0132	CrCbGaD
Oxcarbazepine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00236	0.00288	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Parkinson's disease	0.00232	0.00284	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—MERTK—Parkinson's disease	0.00231	0.00282	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—DOCK3—Parkinson's disease	0.00231	0.00282	CbGpPWpGaD
Oxcarbazepine—Nortriptyline—CYP2D6—Parkinson's disease	0.00231	0.0128	CrCbGaD
Oxcarbazepine—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	0.0023	0.00281	CbGpPWpGaD
Oxcarbazepine—Promethazine—HTR2A—Parkinson's disease	0.00229	0.0127	CrCbGaD
Oxcarbazepine—Imipramine—DRD2—Parkinson's disease	0.00228	0.0126	CrCbGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—SOD2—Parkinson's disease	0.00227	0.00277	CbGpPWpGaD
Oxcarbazepine—Amitriptyline—DRD2—Parkinson's disease	0.00227	0.0126	CrCbGaD
Oxcarbazepine—Doxepin—HTR2A—Parkinson's disease	0.00226	0.0126	CrCbGaD
Oxcarbazepine—SCN5A—Axon guidance—ABL1—Parkinson's disease	0.00225	0.00274	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—CYP2D6—Parkinson's disease	0.00222	0.0027	CbGpPWpGaD
Oxcarbazepine—Imipramine—CYP2E1—Parkinson's disease	0.0022	0.0122	CrCbGaD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00219	0.00267	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00218	0.00267	CbGpPWpGaD
Oxcarbazepine—Amitriptyline—CYP2E1—Parkinson's disease	0.00218	0.0121	CrCbGaD
Oxcarbazepine—Trimipramine—CYP2D6—Parkinson's disease	0.00217	0.012	CrCbGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.00216	0.00264	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00216	0.00263	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—HSPA8—Parkinson's disease	0.00214	0.00262	CbGpPWpGaD
Oxcarbazepine—Clobazam—ABCB1—Parkinson's disease	0.00213	0.0118	CrCbGaD
Oxcarbazepine—Promethazine—CYP2D6—Parkinson's disease	0.00209	0.0116	CrCbGaD
Oxcarbazepine—Desipramine—HTR2A—Parkinson's disease	0.00208	0.0115	CrCbGaD
Oxcarbazepine—Doxepin—CYP2D6—Parkinson's disease	0.00207	0.0115	CrCbGaD
Oxcarbazepine—ALB—Hemostasis—DGKQ—Parkinson's disease	0.00206	0.00251	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—CYP2E1—Parkinson's disease	0.00203	0.00247	CbGpPWpGaD
Oxcarbazepine—Promazine—HTR2A—Parkinson's disease	0.00201	0.0112	CrCbGaD
Oxcarbazepine—SCN5A—Developmental Biology—DLG4—Parkinson's disease	0.00201	0.00246	CbGpPWpGaD
Oxcarbazepine—Carbamazepine—ABCB1—Parkinson's disease	0.002	0.0111	CrCbGaD
Oxcarbazepine—ALB—Folate Metabolism—INS—Parkinson's disease	0.002	0.00244	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.002	0.00244	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.002	0.00244	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00199	0.00243	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.00198	0.00242	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—GRIN2B—Parkinson's disease	0.00197	0.0024	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00194	0.00237	CbGpPWpGaD
Oxcarbazepine—Desipramine—CYP2D6—Parkinson's disease	0.0019	0.0105	CrCbGaD
Oxcarbazepine—ALB—SLC-mediated transmembrane transport—SLC18A2—Parkinson's disease	0.00186	0.00227	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—IL1B—Parkinson's disease	0.00183	0.00224	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.00178	0.00218	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.00178	0.00218	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00177	0.00216	CbGpPWpGaD
Oxcarbazepine—Imipramine—HTR2A—Parkinson's disease	0.00176	0.00977	CrCbGaD
Oxcarbazepine—Amitriptyline—HTR2A—Parkinson's disease	0.00175	0.00971	CrCbGaD
Oxcarbazepine—ALB—SLC-mediated transmembrane transport—CP—Parkinson's disease	0.00171	0.00209	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	0.00171	0.00209	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00169	0.00206	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—COMT—Parkinson's disease	0.00168	0.00205	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—GSTP1—Parkinson's disease	0.00167	0.00204	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—MAOA—Parkinson's disease	0.00167	0.00203	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—COMT—Parkinson's disease	0.00166	0.00202	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00165	0.00201	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	0.00162	0.00198	CbGpPWpGaD
Oxcarbazepine—Imipramine—CYP2D6—Parkinson's disease	0.00161	0.00893	CrCbGaD
Oxcarbazepine—SCN5A—Developmental Biology—ABL1—Parkinson's disease	0.0016	0.00196	CbGpPWpGaD
Oxcarbazepine—Amitriptyline—CYP2D6—Parkinson's disease	0.0016	0.00888	CrCbGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.0016	0.00195	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—INS—Parkinson's disease	0.00159	0.00194	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.00157	0.00191	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.00155	0.0019	CbGpPWpGaD
Oxcarbazepine—Trimipramine—ABCB1—Parkinson's disease	0.00155	0.0086	CrCbGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00154	0.00188	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—GSTM1—Parkinson's disease	0.00154	0.00187	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00153	0.00187	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00151	0.00185	CbGpPWpGaD
Oxcarbazepine—Promethazine—ABCB1—Parkinson's disease	0.00149	0.00828	CrCbGaD
Oxcarbazepine—ALB—Folate Metabolism—IL1B—Parkinson's disease	0.00149	0.00182	CbGpPWpGaD
Oxcarbazepine—Doxepin—ABCB1—Parkinson's disease	0.00148	0.0082	CrCbGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00146	0.00178	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.00144	0.00176	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00143	0.00175	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.00139	0.00169	CbGpPWpGaD
Oxcarbazepine—Desipramine—ABCB1—Parkinson's disease	0.00136	0.00752	CrCbGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—TNF—Parkinson's disease	0.00133	0.00162	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—MAG—Parkinson's disease	0.00133	0.00162	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.0013	0.00158	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.00129	0.00158	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.00129	0.00157	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.00128	0.00156	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00127	0.00155	CbGpPWpGaD
Oxcarbazepine—Diazepam—ABCB1—Parkinson's disease	0.00125	0.00691	CrCbGaD
Oxcarbazepine—ALB—SLC-mediated transmembrane transport—SLC6A3—Parkinson's disease	0.00122	0.00149	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.00121	0.00147	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.00119	0.00145	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.00119	0.00145	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00117	0.00143	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.00116	0.00142	CbGpPWpGaD
Oxcarbazepine—Imipramine—ABCB1—Parkinson's disease	0.00115	0.00638	CrCbGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.00115	0.0014	CbGpPWpGaD
Oxcarbazepine—Amitriptyline—ABCB1—Parkinson's disease	0.00114	0.00634	CrCbGaD
Oxcarbazepine—CYP3A5—Metabolism—MCCC1—Parkinson's disease	0.00109	0.00133	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ND3—Parkinson's disease	0.00109	0.00133	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—TNF—Parkinson's disease	0.00108	0.00132	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.00108	0.00132	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—IL6—Parkinson's disease	0.00107	0.00131	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—INS—Parkinson's disease	0.00106	0.00129	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.00103	0.00126	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—OMD—Parkinson's disease	0.00102	0.00125	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—TALDO1—Parkinson's disease	0.00102	0.00125	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00102	0.00124	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000996	0.00121	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	0.00097	0.00118	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	0.000947	0.00116	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000942	0.00115	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ND3—Parkinson's disease	0.000938	0.00114	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MCCC1—Parkinson's disease	0.000938	0.00114	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000929	0.00113	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GCH1—Parkinson's disease	0.000926	0.00113	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000894	0.00109	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—TALDO1—Parkinson's disease	0.000881	0.00108	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—OMD—Parkinson's disease	0.000881	0.00108	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—IL6—Parkinson's disease	0.000874	0.00107	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	0.000871	0.00106	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	0.00086	0.00105	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ND3—Parkinson's disease	0.000842	0.00103	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MCCC1—Parkinson's disease	0.000842	0.00103	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—FGB—Parkinson's disease	0.000838	0.00102	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NDUFB11—Parkinson's disease	0.000836	0.00102	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GBA—Parkinson's disease	0.000825	0.00101	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—DBH—Parkinson's disease	0.000825	0.00101	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—FBP1—Parkinson's disease	0.000825	0.00101	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GCH1—Parkinson's disease	0.000797	0.000973	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—TALDO1—Parkinson's disease	0.000791	0.000965	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—OMD—Parkinson's disease	0.000791	0.000965	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.00078	0.000952	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000777	0.000948	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000775	0.000946	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.00077	0.000939	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000766	0.000935	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	0.00075	0.000915	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000719	0.000877	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GCH1—Parkinson's disease	0.000716	0.000873	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000714	0.000871	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—FBP1—Parkinson's disease	0.000711	0.000867	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—DBH—Parkinson's disease	0.000711	0.000867	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GBA—Parkinson's disease	0.000711	0.000867	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000704	0.000859	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000694	0.000847	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—IL6—Parkinson's disease	0.000649	0.000792	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000645	0.000788	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GBA—Parkinson's disease	0.000638	0.000778	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—FBP1—Parkinson's disease	0.000638	0.000778	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—DBH—Parkinson's disease	0.000638	0.000778	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SOD1—Parkinson's disease	0.000622	0.000759	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000621	0.000757	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—DDC—Parkinson's disease	0.000606	0.000739	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000596	0.000727	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—ABL1—Parkinson's disease	0.000593	0.000724	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IGF2—Parkinson's disease	0.000591	0.000721	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—TNF—Parkinson's disease	0.000574	0.0007	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTA4—Parkinson's disease	0.000572	0.000698	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—HGF—Parkinson's disease	0.000558	0.00068	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—DDC—Parkinson's disease	0.000522	0.000636	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000518	0.000632	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	0.000515	0.000628	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—MAOB—Parkinson's disease	0.00051	0.000622	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000506	0.000617	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000506	0.000617	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000497	0.000607	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTA4—Parkinson's disease	0.000492	0.000601	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000486	0.000593	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000476	0.000581	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000476	0.000581	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—DDC—Parkinson's disease	0.000468	0.000571	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—IL6—Parkinson's disease	0.000463	0.000565	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000451	0.00055	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PLA2G6—Parkinson's disease	0.000443	0.000541	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTA4—Parkinson's disease	0.000442	0.000539	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MAOB—Parkinson's disease	0.000439	0.000536	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000437	0.000533	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.00043	0.000525	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000418	0.00051	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	0.000398	0.000486	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MAOB—Parkinson's disease	0.000394	0.000481	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000384	0.000468	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000384	0.000468	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000384	0.000468	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	0.000379	0.000462	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000375	0.000458	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CTGF—Parkinson's disease	0.000372	0.000454	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	0.000346	0.000423	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NQO1—Parkinson's disease	0.000343	0.000418	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—TH—Parkinson's disease	0.000338	0.000412	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP2D6—Parkinson's disease	0.000326	0.000398	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYCS—Parkinson's disease	0.000324	0.000396	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CTGF—Parkinson's disease	0.00032	0.000391	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP2E1—Parkinson's disease	0.000298	0.000364	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NQO1—Parkinson's disease	0.000295	0.00036	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	0.000293	0.000357	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—TH—Parkinson's disease	0.000291	0.000355	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CTGF—Parkinson's disease	0.000287	0.000351	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—COMT—Parkinson's disease	0.000287	0.00035	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTP1—Parkinson's disease	0.000286	0.000349	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—MAOA—Parkinson's disease	0.000285	0.000348	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—HMOX1—Parkinson's disease	0.000282	0.000344	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000282	0.000343	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYCS—Parkinson's disease	0.000279	0.000341	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ABCB1—Parkinson's disease	0.00027	0.00033	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	0.000268	0.000327	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000266	0.000324	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NQO1—Parkinson's disease	0.000265	0.000323	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTM1—Parkinson's disease	0.000263	0.00032	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—TH—Parkinson's disease	0.000261	0.000318	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GPX1—Parkinson's disease	0.000251	0.000307	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYCS—Parkinson's disease	0.000251	0.000306	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—COMT—Parkinson's disease	0.000247	0.000302	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTP1—Parkinson's disease	0.000246	0.0003	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MAOA—Parkinson's disease	0.000245	0.0003	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HMOX1—Parkinson's disease	0.000243	0.000296	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000239	0.000292	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000237	0.000289	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ABCB1—Parkinson's disease	0.000233	0.000284	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—MTHFR—Parkinson's disease	0.000232	0.000283	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTM1—Parkinson's disease	0.000226	0.000276	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—COMT—Parkinson's disease	0.000222	0.000271	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	0.000221	0.00027	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MAOA—Parkinson's disease	0.00022	0.000269	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	0.000218	0.000266	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GPX1—Parkinson's disease	0.000217	0.000264	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—APOE—Parkinson's disease	0.000216	0.000264	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	0.000209	0.000255	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	0.000203	0.000248	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—MTHFR—Parkinson's disease	0.0002	0.000244	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GPX1—Parkinson's disease	0.000194	0.000237	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—APOE—Parkinson's disease	0.000186	0.000227	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—INS—Parkinson's disease	0.000185	0.000225	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	0.000179	0.000219	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	0.000176	0.000215	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CTGF—Parkinson's disease	0.000173	0.000211	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—APOE—Parkinson's disease	0.000167	0.000204	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	0.000161	0.000197	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NQO1—Parkinson's disease	0.000159	0.000194	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—INS—Parkinson's disease	0.000159	0.000194	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—TH—Parkinson's disease	0.000157	0.000192	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYCS—Parkinson's disease	0.000151	0.000184	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—INS—Parkinson's disease	0.000143	0.000174	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—COMT—Parkinson's disease	0.000133	0.000163	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	0.000133	0.000162	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MAOA—Parkinson's disease	0.000133	0.000162	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	0.000131	0.00016	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	0.000126	0.000153	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	0.000122	0.000149	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GPX1—Parkinson's disease	0.000117	0.000143	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	0.000108	0.000132	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—APOE—Parkinson's disease	0.0001	0.000123	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—INS—Parkinson's disease	8.58e-05	0.000105	CbGpPWpGaD
